Statements (63)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Cell
|
gptkbp:enhances |
antigen presentation
B cell antibody production macrophage activation |
gptkbp:function |
immune response modulation
|
https://www.w3.org/2000/01/rdf-schema#label |
IFN-gamma
|
gptkbp:increased |
nitric oxide production
MHC class II expression |
gptkbp:initiated_by |
tumor growth
viral replication Th2 cell differentiation |
gptkbp:involved_in |
gptkb:virus
gptkb:asthma gptkb:chronic_fatigue_syndrome gptkb:cystic_fibrosis gptkb:Crohn's_disease gptkb:systemic_lupus_erythematosus gptkb:rheumatoid_arthritis gptkb:neurodegenerative_diseases gptkb:multiple_sclerosis eye diseases genetic disorders liver diseases allergic reactions autoimmune diseases metabolic syndrome obesity neuroinflammation hearing loss cardiovascular diseases chronic kidney disease fibromyalgia infectious diseases musculoskeletal disorders psoriasis skin diseases chronic inflammation aging process graft rejection gastrointestinal diseases chronic obstructive pulmonary disease hematological disorders type 1 diabetes endocrine disorders cancer immunotherapy neoplasms dental diseases sepsis response HIV response environmental diseases toxicological responses tuberculosis response |
gptkbp:is_vulnerable_to |
gptkb:IFN-gamma_receptor
|
gptkbp:pathway |
JAK-STAT pathway
|
gptkbp:produced_by |
gptkb:T_cells
natural killer cells |
gptkbp:promoter |
gptkb:IFNG
|
gptkbp:regulates |
T cell differentiation
|
gptkbp:research_areas |
gptkb:cancer_treatment
viral infections treatment |
gptkbp:bfsParent |
gptkb:IFN
gptkb:Il-18_E |
gptkbp:bfsLayer |
7
|